Active, not recruiting
Real-world Study of Sacituzumab Govitecan Monotherapy or Combination Therapy in Recurrent or Metastatic HER2-negative Breast Cancer
NCT07018427
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more
- Locations
-
- Peking University Cancer Hospital & Institute Beijing, Beijing Municipality, China